CA2325337C - Utilisation d'un derive de levure vivante pour traiter des escarres de decubitus - Google Patents

Utilisation d'un derive de levure vivante pour traiter des escarres de decubitus Download PDF

Info

Publication number
CA2325337C
CA2325337C CA002325337A CA2325337A CA2325337C CA 2325337 C CA2325337 C CA 2325337C CA 002325337 A CA002325337 A CA 002325337A CA 2325337 A CA2325337 A CA 2325337A CA 2325337 C CA2325337 C CA 2325337C
Authority
CA
Canada
Prior art keywords
composition
lycd
yeast cell
resolved
live yeast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002325337A
Other languages
English (en)
Other versions
CA2325337A1 (fr
Inventor
Steven Hernandez
Burt Shaffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Topix Pharmaceuticals Inc
Original Assignee
Topix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topix Pharmaceuticals Inc filed Critical Topix Pharmaceuticals Inc
Publication of CA2325337A1 publication Critical patent/CA2325337A1/fr
Application granted granted Critical
Publication of CA2325337C publication Critical patent/CA2325337C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Composition stable est prévue pour traiter et/ou prévenir les plaies de pression (escarres de décubitus) et les troubles de la peau, par application topique sur la peau, la composition de traitement contenant une quantité efficace d'un composé comprenant un dérivé de levure vivante (LYCD), dans un véhicule anhydre pharmaceutiquement acceptable tel que le pétrolatum en tant qu'occlusion en combinaison avec un solvant, tel que de l'huile de foie de requin. La présente invention comprend l'utilisation d'une pommade de protection de la peau en vente libre (OTC) contenant un dérivé de levure vivante (LYCD) biologiquement active qui s'avère efficace dans le traitement des escarres de décubitus dans des essais cliniques. L'invention permet de minimiser le risque d'infection, l'inconfort du patient et les temps de récupération, ainsi que d'assurer un environnement humide pour faciliter la guérison et la protection de la peau.
CA002325337A 1999-11-10 2000-11-09 Utilisation d'un derive de levure vivante pour traiter des escarres de decubitus Expired - Fee Related CA2325337C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16489599P 1999-11-10 1999-11-10
US60/164,895 1999-11-10

Publications (2)

Publication Number Publication Date
CA2325337A1 CA2325337A1 (fr) 2001-05-10
CA2325337C true CA2325337C (fr) 2009-12-15

Family

ID=22596565

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002325337A Expired - Fee Related CA2325337C (fr) 1999-11-10 2000-11-09 Utilisation d'un derive de levure vivante pour traiter des escarres de decubitus

Country Status (1)

Country Link
CA (1) CA2325337C (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US10279007B2 (en) * 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs

Also Published As

Publication number Publication date
CA2325337A1 (fr) 2001-05-10

Similar Documents

Publication Publication Date Title
US11571452B2 (en) Method of treating a skin wound with a liquid-state topical pharmaceutical composition
JP6495183B2 (ja) 表面の創傷を処置するための組成物および方法
CN108853312B (zh) 聚桂醇外用凝胶及其制备方法
KR100315583B1 (ko) 흉터를아물게하는활성을가진국소약물
US8409628B2 (en) Methods and compositions for oxygenation of skin to treat skin disorders
US7597911B2 (en) Method and composition for treatment of wounds and burns
US20050164924A1 (en) Method and composition for treating skin wounds with epidermal growth factor
US20210236446A1 (en) Wound healing composition
US6342255B1 (en) Topical pharmaceutical compositions useful for the treatment of cutaneous of circulatory pathologies on inflammatory, immune, proliferative of degenerative basis
EP1077725B1 (fr) Compositions pharmaceutiques topiques utiles dans le traitement de pathologies cutanees ou circulatoires sur une base inflammatoire, immune, proliferative ou degenerative
CA2325337C (fr) Utilisation d'un derive de levure vivante pour traiter des escarres de decubitus
WO1994005272A1 (fr) Compositions destinees au traitement de l'epiderme, contenant du dimethylsulfone et du dimethylsulfoxyde
US20090263500A1 (en) Composition and method for treating bedsores, cuts and burns
US4829082A (en) Pharmaceutical compositions for the treatment of skin diseases
Knight Medical management of pressure sores
JP2018000390A (ja) 酸性人工角質形成型製剤
EP2343044A1 (fr) Composition cosmétique pour peaux sensibles
WO2007084127A1 (fr) Utilisation de gluten en tant qu'agent cicatrisant pour le traitement de plaies
KR102205025B1 (ko) 흉터의 예방 또는 치료를 위한 조성물
US20240091190A1 (en) Skin cream for reducing bed sores
WO2004096119A2 (fr) Compositions pharmaceutiques topiques, procedes de preparation de ces compositions et articles manufactures contenant ces dernieres
JPH04128219A (ja) 皮膚潰瘍治療用貼付剤
CN114177219A (zh) 皮肤药物组合物及其制备方法
JP2008044916A (ja) 褥瘡治療薬
KR20190116227A (ko) 흉터의 예방 또는 치료를 위한 조성물

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20171109

MKLA Lapsed

Effective date: 20171109